Article Details
Retrieved on: 2018-05-08 07:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC purchased a new stake in shares of Nektar Therapeutics (NASDAQ:NKTR) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 91,848 shares of the biopharmaceutical company's stock, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here